The government of Australia has sealed a deal with AstraZeneca to supply enough doses of the adenovirus vector-based vaccine being developed on behalf of Oxford...
In a much heeded licensing deal, AstraZeneca (AZ) has awarded Chinese pharma BioKangta sole commercial rights to its AZD1222 Covid-19 vaccine candidate in the People’s...
UK-Swedish drugmaker AstraZeneca has entered into a global development and commercialization agreement with Daiichi Sankyo, which could be worth up to $6 billion for the...
European officials recently began talking to companies developing Covid-19 vaccines about supplying the EU’s 27 member states, in hope that none would fall behind bigger...
09.06.2020
- Anglo-Swedish drugmaker AstraZeneca is weighing a merger with US biotech Gilead Sciences, the Bloomberg news agency has reported. Surpassing Bristol Myers Squibb’s $74 billion...
04.06.2020
- Contract development and manufacturing organization (CDMO) AGC Biologics has bought AstraZeneca’s commercial manufacturing facility in Boulder, Colorado, USA. AGC said the large...
22.05.2020
- The US Biomedical Advanced Research and Development Authority (BARDA) has added another illustrious European pharmaceutical industry player to the list of those whose resources it...
19.05.2020
- Anglo-Swedish drugmaker AstraZeneca has announced it will make as many as 30 million initial doses of a potential Covid-19 vaccine available by September this year, assuming the...
